CircuLex S100A12/EN-RAGE ELISA Kit Ver.2

  • Species Reactivities Human
  • Code # CY-8058V2
  • Size 96 Assay
  • Price
    $595.00
Specifications

Alternative Names

CAGC, CGRP,  MRP-6,  CAAF1

  • Description:
    This Kit is used for the quantitative measurement of human S100A12/EN-RAGE in serum, plasma, and other biological media.
  • Product Type:
    Kit
  • Size:
    96 Assay
  • Species Reactivity:
    Human
  • Storage Temperature:
    4°C
Citations
  1. Andrés Cerezo L et al. Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther.  13, R122 (2011)Bae CB et al. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease. J Rheumatol. 41, 2403-8 (2014),
  2. Bae CB et al. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease. J Rheumatol.  41, 2403-8 (2014)
  3. Farkas G Jr et al. Analysis of plasma levels and polymorphisms of S100A8/9 and S100A12 in patients with acute pancreatitis. Pancreas. 43, 485-7 (2014),
  4. Fukasawa H et al. Plasma levels of the pro-inflammatory protein S100A12 (EN-RAGE) are associated with muscle and fat mass in hemodialysis patients: a cross-sectional study. Nutr J. 13, 48 (2014),
  5. Glasnovic A et al. Decreased level of sRAGE in the cerebrospinal fluid of multiple sclerosis patients at clinical onset. Neuroimmunomodulation. 21, 226-33 (2014),
  6. Han EC et al. Expression of Pro-inflammatory Protein S100A12 (EN-RAGE) in Beh_et's Disease and Its Association with Disease Activity: A Pilot Study. Ann Dermatol. 23, 313-20 (2011)
  7. Hara M et al. S100A12 gene expression is increased in peripheral leukocytes in chronic kidney disease stage 4-5 patients with cardiovascular disease. Nephron Clin Pract. 123, 202-8 (2013),
  8. He YY et al. Usefulness of S100A12 as a prognostic biomarker for adverse events in patients with heart failure. Clin Biochem. 48, 329-33 (2015),
  9. Isoyama N et al. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients. Nephrol Dial Transplant. 30, 84-91 (2014),
  10. Kim HS et al. Circulating levels of soluble receptor for advanced glycation end product are inversely associated with vascular calcification in patients on haemodialysis independent of S100A12 (EN-RAGE) levels. Nephrology 18, :777-82 (2013),
  11. Kim JK et al. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis. Atherosclerosis 220, 208-14 (2012)
  12. Liu K, et al.; Transcriptome signature in young children with acute otitis media due to Streptococcus pneumoniae. Microbes Infect. 14: 600-9. 2012,
  13. Opatrna S et al. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products. Ther Apher Dial. 18, 309-16 (2014),
  14. Peiskerová M et al. Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease--a prospective observational study. BMC Nephrol. 14, 142 (2013),
  15. Rothmund F et al. Validation of relapse risk biomarkers for routine use in patients with juvenile idiopathic arthritis. Arthritis Care Res. 66, 949-55 (2014),
  16. Saito T et al. Distinct expression patterns of alveolar "alarmins" in subtypes of chronic lung allograft dysfunction. Am J Transplant. 14, 1425-32 (2014),
  17. Silajdžić E et al. A critical evaluation of inflammatory markers in Huntington's Disease plasma. J Huntingtons Dis. 2, 125-34 (2013),
  18. Smith DJ, et al. Reduced soluble receptor for advanced glycation end products in chronic obstructive pulmonary disease. Eur Respir J, 37: 516-22, 2011,
  19. Sundqvist M et al. Increased intracellular oxygen radical production in neutrophils during febrile episodes of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome. Arthritis Rheum. 65, 2971-83 (2013),
  20. Takahashi G et al.Retrospective study on the effect of tight glucose control in postoperative sepsis patients using an artificial pancreas. J Infect Chemother.17, 812-20 (2011)
  21. Takahashi G et al. Changes in Serum S100A12 and sRAGE Associated with Improvement of the PaO(2)/FiO(2) Ratio following PMX-DHP Therapy for Postoperative Septic Shock. Eur Surg Res. 47, 135-140 (2011)
  22. Tydén H et al. Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus. Rheumatology Rheumatology 52, 2048-55 (2013),
  23. Yamamoto T et al. Changes in circulating biomarkers during a single hemodialysis session. Hemodial Int. 17, 59-66 (2013),
  24. Zakiyanov O et al. Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: a cross sectional study. BMC Nephrol. 14, 245 (2013),
  25. Kikkawa T et al. Significance of measuring S100A12 and sRAGE in the serum of sepsis patients with postoperative acute lung injury. Dig Surg. 27, 307-312 (2010)
  26. Nakashima A et al. Effect of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) and the Proinflammatory RAGE Ligand (EN-RAGE, S100A12) on Mortality in Hemodialysis Patients. Clin J Am Soc Nephrol. 5, 2213-9 (2010)
  27. Scher JU et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol.  67, 128-39 (2015)
  28. Ingels C et al. Soluble RAGE and the RAGE ligands HMGB1 and S100A12 in critical illness: Impact of glycemic control with insulin and relation with clinical outcome. Shock.  43, 109-16 (2015)
  29. Mulrennan S et al. The role of receptor for advanced glycation end products in airway inflammation in CF and CF related diabetes. Sci Rep.  5, 8931 (2015)
  30. Kovach MA et al. Microarray analysis identifies IL-1 receptor type 2 as a novel candidate biomarker in patients with acute respiratory distress syndrome. Respir Res.  16, 29 (2015)
  31. Turnier JL et al. Urine S100 proteins as potential biomarkers of lupus nephritis activity. Arthritis Res Ther. 19, 242(2017)